3. KIDNEY TRANSPLANTATION FROM LIVING DONOR WITH RENAL MASS: CLINICAL CASE

Authors

DOI:

https://doi.org/10.35805/BSK2024II003

Downloads

Abstract

Introduction. Renal transplantation is the best treatment option for end-stage renal disease, but organ demand continues to overweight organ supply. The transplantation of kidneys from donors with small renal masses represent a potential avenue to expand the donor pool. We represent the clinical case of kidney transplantation from living related donor with small renal mass and performed literature review of results of these cases.

Methods. Саse presentation of kidney transplantation from living related donor with incidental finding of small renal mass. Mass was excised and subsequently kidney was engrafted successfully. Up to date both patients are under follow up during 8 months and any signs of recurrence were seen.

Results. Donor kidney was procuredby laparosopic hand-assissted technique. Intraoperatively small renal mass was encountered whereas during preop evaluation renal cyst was diagnosed. Renal mass was excised fully and defect was closed with interruptive suture. Histological evaluation has revealed highly differentiated renal cell carcinoma. Postoperative period was uneventful. Patient was discharged with good graft function.

Conclusion. Careful use of kidneys from donors with single renal masses is feasible and safe, with an overall recurrence rate of less than 1.5%. The use of such kidneys could help alleviate the organ shortage crisis.

Keywords

Renal Mass, Transplantation

References

  1. Chaudhry D, Chaudhry A, Peracha J, Sharif A. Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis. BMJ. Mar 01 2022;376:e068769. doi:10.1136/bmj-2021-068769
  2. Strohmaier S, Wallisch C, Kammer M, et al. Survival Benefit of First Single-Organ Deceased Donor Kidney Transplantation Compared With Long-term Dialysis Across Ages in Transplant-Eligible Patients With Kidney Failure. JAMA Netw Open. Oct 03 2022;5(10):e2234971. doi:10.1001/jamanetworkopen.2022.34971
  3. Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. Oct 2011;11(10):2093-109. doi:10.1111/ j.1600-6143.2011.03686.x
  4. Knoll GA, Tinckam KJ. Organ Donation and Transplantation: The View From Canada. Transplantation. Nov 2015;99(11):2231-3. doi:10.1097/ TP.0000000000000919
  5. Rose C, Schaeffner E, Frei U, Gill J, Gill JS. A Lifetime of Allograft Function with Kidneys from Older Donors. J Am Soc Nephrol. Oct 2015;26(10):248393. doi:10.1681/ASN.2014080771
  6. Summers DM, Watson CJ, Pettigrew GJ, et al. Kidney donation after circulatory death (DCD): state of the art. Kidney Int. Aug 2015;88(2):241-9. doi:10.1038/ki.2015.88
  7. Van Poppel H, Becker F, Cadeddu JA, et al. Treatment of localised renal cell carcinoma. Eur Urol. Oct 2011;60(4):662pretation. All authors have approved the final version of the article. Funding: This research has been funded by the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan (Grant No. BR24992769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 72. doi:10.1016/j.eururo.2011.06.040
  8. Russo P. Localized renal cell carcinoma. Curr Treat Options Oncol. Oct 2001;2(5):447-55. doi:10.1007/s11864001-0050-4
  9. Vigneswaran HT, Lec P, Brito J, Turini G, Pareek G, Golijanin D. Partial Nephrectomy for Small Renal Masses: Do Teaching and Nonteaching Institutions Adhere to Guidelines Equally? J Endourol. Jun 2016;30(6):714-21. doi:10.1089/end.2016.0112
  10. Lavallée LT, Tanguay S, Jewett MA, et al. Surgical management of stage T1 renal tumours at Canadian academic centres. Can Urol Assoc J. 2015;9(34):99-106. doi:10.5489/cuaj.2598
  11. Krishnan A, Wong G, Teixeira-Pinto A, Lim WH. Incidence and Outcomes of Early Cancers After Kidney Transplantation. Transpl Int. 2022;35:10024. doi:10.3389/ti.2022.10024
  12. Acuna SA, Fernandes KA, Daly C, et al. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada. JAMA Oncol. Apr 2016;2(4):463-9. doi:10.1001/jamaoncol.2015.5137
  13. Traitanon O, Gallon L. Indications for Renal Transplantation: Evaluation of Transplant Candidates. Kidney Transplantation, Bioengineering and Regeneration. Elsevier; 2017:187-197
  14. Mamode N, Bestard O, Claas F, et al. European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group. Transpl Int. 2022;35:10511. doi:10.3389/ti.2022.10511 WITH RENAL MASS: CLINICAL CASE
  15. Donat SM, Diaz M, Bishoff JT, et al. Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol. Aug 2013;190(2):407-16. doi:10.1016/j.juro.2013.04.121
  16. Piana A, Andras I, Diana P, et al. Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients. Asian J Urol. Jul 2022;9(3):208-214. doi:10.1016/j.ajur.2022.06.001
  17. He B, Ng ZQ, Mou L, et al. Long-term outcome of kidney transplant by using restored kidney grafts after tumour ex vivo excision–a prospective study. Transplant International. 2020;33(10):1253-1261

Published

2024-06-28

Issue

No. 2 (2024)

Section

Статьи